Insights

345 Park Avenue South

Xchange Challenge

All floors are lab-ready and cabled for digital health.

Community

Residents

Leadership

Staff

Neighborhood

Be part of *Cure.*

Orange

Where scientists, entrepreneurs and visionaries converge.

Campus

Ecosystem

Event Spaces

Gallery

Networking hub

Space Availability

A place to *Succeed.*

Green

Joe Wilson How Life Sciences Companies Use AI to Target Investors Mega Menu Image 

Critical Discussions Advancing Healthcare

Events

Event Inquiry

Past Events

Speakers

Tuesday Talks

Cure *Events.*

Magenta

Cure Clips

Tuesday Talks Series

Cure *Tuesday Talks*

Award Finalists to be announced soon!

Partnerships and Sponsorships

Women in Science

XSeed Award

Connect with *Opportunity.*

Blue

Network

Cure Insights Article A Bionic Pancreas that will Help Parents Sleep More Peacefully image for Cure Insights Mega Menu.  Image credit Cottonbro Studio.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

In-depth *Insights.*

About

Contact us

Stay updated on platform news and potential beta tests.

Regular

Jim Geraghty, JD, MS, is a strategic leader in biotechnology company building and board governance with more than three decades of experience. 

Today, he chairs the boards of Orchard Therapeutics and Pieris Pharmaceuticals and serves on the boards of Voyager Therapeutics, Fulcrum Therapeutics, and CANbridge. He is a director of BIO Ventures for Global Health (BVGH), a global health nonprofit.

Geraghty previously served as an Entrepreneur in Residence at Third Rock Ventures, a leading life sciences company creation fund, and as Senior VP, Global Strategy, at Sanofi, a top-five pharma company. He spent more than 20 years at Genzyme, a pioneering biotech company, including serving as President of Genzyme Transgenics to Genzyme Europe.

He started his career as a strategy consultant at Bain and is a graduate of the Yale Law School with a master's degreein psychology from the University of Pennsylvania and a bachelor's degree from Georgetown University.

Chair of the Board, Orchard Theraputics & Pieris Pharmaceuticals 

Entrepreneur, investor, and former Genzyme executive Jim Geraghty, JD, MS, discusses how biotech companies can overcome the many hurdles faced in developing treatments for rare and serious diseases.

Cure Tuesday Talks banner image Jim Geraghty 

How to Build a Company and Tackle the Toughest Diseases